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The chemokine receptor antagonist AOP-RANTES reduces of chemotaxis is still not fully understood. Some recep-
monocyte infiltration in experimental glomerulonephritis. tors are restricted to certain cells, whereas others are
Background. This study was designed to evaluate the role more widely expressed. A few of the receptors bind toof the novel chemokine receptor antagonist amino-oxypentane
only one chemokine, but others interact with severalRANTES (AOP-RANTES), which blocks the binding of mac-
rophage inflammatory protein-1a (MIP-1a), MIP-1b, and chemokines [4, 5].
RANTES to the chemokine receptor-5 (CCR-5) on the infil- In animal models of glomerulonephritis, chemokine-
tration of monocytes in experimental glomerulonephritis. neutralizing approaches have shown that antibodies toMethods. Rats were treated twice daily with 12.5 mg AOP-
interleukin-8 (IL-8) or monocyte chemoattractant pro-RANTES following an induction of anti–rat-thymocyte anti-
body-mediated glomerulonephritis. The white blood cell count, tein-1 (MCP-1) can reduce the infiltration of either poly-
glomerular monocyte infiltration, chemokine expression, and morphonuclear granulocytes, monocytes, or lymphocytes
collagen type IV deposition were assessed. [6–10]. However, these approaches lead to only a 40 toResults. The induction of glomerulonephritis increased glo-
50% impairment of leukocyte infiltration, suggesting thatmerular monocyte/macrophage (M/M) infiltration at 24 hours
more than one single chemokine is responsible for leuko-and at 5 days was still higher than in controls. AOP-RANTES
prevented glomerular M/M infiltration at 24 hours and at 5 cyte recruitment. In fact, studies in the animal model of
days. This was paralleled by reduced glomerular collagen type anti-glomerular basement membrane nephritis showed
IV deposition as a fibrotic marker in nephritic animals.
that in the development of glomerulonephritis, an up-Conclusion. These data show that the CCR-5 chemokine
regulation of several chemokines appears [11]. In additionreceptor antagonist AOP-RANTES ameliorates M/M infiltra-
tion and improves glomerular pathology in experimental glo- to MCP-1, particularly macrophage inflammatory pro-
merulonephritis. The use of chemokine receptor antagonists tein-1a (MIP-1a), interferon produced protein-10 (IP-10),
may offer a new therapeutic option in inflammatory renal injuries.
macrophage inflammatory protein-2 (MIP-2), and regu-
lated on activated normal T cell expressed and secreted
(RANTES) were increased. The blockade of one or moreChemokines are small secreted proteins that stimulate
chemokines would be desirable as a potential therapeuticthe directional migration of leukocytes and mediate in-
approach. Because most chemokine receptors on leuko-flammation [1]. The important role of chemokines in renal
cytes bind more than one chemokine, the blockade ofdiseases has recently been reviewed [2, 3]. They exert their
chemokine receptors could be a more efficient option.effects through binding on chemokine receptors [4, 5],
The recent development of amino-oxypentane (AOP)-predominantly expressed on leukocytes. Chemokine re-
RANTES, which is a modified chemokine (a derivativeceptors are member of the seven-membrane–spanning,
of RANTES that was created by chemical modificationG-protein–coupled receptor family. The mechanism of
of the amino terminus) and a potent antagonist of thecoupling chemokine receptor activation to the process
chemokine receptor-5 (CCR-5) on monocytes [12, 13], al-
lowed us to study the possible role of a receptor antagonist
Key words: monocyte chemoattractant protein-1, amino-oxypentane- on inflammatory cell recruitment of glomerulonephritis.RANTES, chemokine receptor-5, inflammatory renal injury.
In our experiments, AOP-RANTES reduced glomeru-
lar monocyte infiltration and ameliorated the develop-
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METHODS
Induction of glomerulonephritis and
experimental design
Immune-mediated mesangial cell injury was induced
in male Wistar rats (180 to 200 g/body wt) by intravenous
injection of an anti–rat-thymocyte antiserum (ATS). ATS
was induced in rabbits by repeated immunization with
thymocytes from Lewis rats as described earlier [14].
The following groups of animals were studied (N 5 5
for all groups and each time point): (a) controls, that is,
animals that remained untouched until nephrectomy; (b)
nephritis, animals given 0.5 ml/100 g/body wt ATS intra-
venously 1 0.3 ml of distilled water intravenously; and
(c) animals with nephritis 1 AOP-RANTES, 0.5 ml/100
g/body wt ATS intravenously 1 12.5 mg AOP-RANTES
Fig. 1. Glomerular monocyte/macrophage (M/M) infiltration. The in-in 0.3 ml distilled water intravenously twice daily.
filtration of M/M into the glomerulus was immunohistochemically as-
The experiments were carried out in three complete sets. sessed by staining with an antibody to ED-1. In nephritic animal, ED-
1–positive cells increased significantly at 24 hours. AOP-RANTES re-
duced the glomerular cell number at both time points studied; however,Isolation of glomeruli and total RNA for Northern
the alterations were only significant at 24 hours versus nephritis (*P 5blot hybridization 0.02). The cell numbers are expressed as ED-1–postive cells/glomerular
cross-section. Data are given as means 6 sd.Glomeruli were isolated by a fractional sieving tech-
nique as described earlier [14]. Cellular RNA from glo-
meruli was isolated by the guanidinium isothiocyanate
method [15]. For Northern blot analysis, 20 mg of total
and 1 ml moloney-mouse leukemic virus (M-MLV) re-RNA were size fractionated by electrophoresis on a 1.2%
verse transcriptase (2 U/ml; GIBCO BRL, Eggenstein,agarose-formaldehyde gel and transferred to nylon mem-
Germany) per sample was prepared. The RT reactionbranes (Zetabind; Cuno, Meriden, CT, USA). Equal
was carried out for two hours at 378C. To perform PCR,loading of the lanes was evaluated by ethidium bromide
the following sequence was used based on the followingstaining of the 18 and 28 S RNA. The membranes were
rat cDNA: forward primer, 59CTT GCT GTT CTT CTChybridized with a 577 bp MCP-1 cDNA fragment and a
TGC ACC ATG 39, and reverse primer, 59TCT CTTrat RANTES cDNA fragment previously labeled with
GGT CAG GAA AAT GAC ACC 39 (produced withcytidine triphosphate (CTP) (32P) as described earlier
[16, 17] in hybridization buffer [5 3 SSPE, 2 3 Denhardt’s Oligo 1000 AN Synthesizer; Beckmann, Munich, Ger-
150 mg/ml, sonicated and denatured salmon sperm DNA many). To 5 ml of each sample, 29.5 ml H2O, 5 ml 10 3
(Sigma-Aldrich Chemie, Germany), 0.1% sodium do- PCR-buffer, 3 ml MgCl2 (25 mm), 4 ml dNTPs (2.5 mm),
decyl sulfate (SDS), 5% dextran sulfate, and 50% form- 1.5 ml forward primer (50 ng/ml), 1.5 ml reverse primer
amide] for 18 hours at 428C. The membranes were (50 ng/ml), and 0.5 ml Taq DNA polymerase (5 U/ml;
washed to high stringency in standard saline citrate Promega) were added. PCR was run for 32 cycles using
(SSC)/SDS at 658C as described earlier [15]. Autoradiog- the following temperature profile: denaturation at 958C
raphy was performed for 2 to 72 hours at 2808C. Mem- for 10 seconds, annealing for 20 seconds at 578C, exten-
branes were rehybridized with a 580 bp cDNA probe of sion for 30 seconds at 728C. The length of the amplified
human 18 S RNA to account for small loading and trans- fragment was 180 bp. RNA samples were also analyzed
fer variabilities. Exposed films were quantitated by using
for the expression of the housekeeping gene GAPDH asphosphoimager Bio-Rad-GS-363 (multianalyst software).
described earlier [17]. Amplified cDNA fragments wereNorthern blot experiments were independently per-
separated on a 1.5% agarose gel, which contained 1 mg/mlformed for three different complete sets of experiments
ethidium bromide and was photographed on ultravioletwith qualitatively similar results.
light using a Polaroid 655 film. Genomic DNA artifacts
were ruled out by performing control PCR without RT.RT-PCR for macrophage inflammatory protein-1a
Exposed films were quantitated by using phosphoimagerFor reverse transcription-polymerase chain reaction
Bio-Rad-GS-363 (multianalyst software). RT-PCR ex-(RT-PCR), 1 mg of total RNA, 4 ml 5 3 first strand
periments were independently performed for three dif-buffer, 1 ml dNTPs (20 mm), 2 ml dithiothreitol (0.1 m),
ferent complete sets of experiments with qualitatively0.4 ml poly(dT)primer (1 mg/ml; Pharmacia, Freiburg,
Germany), 0.4 ml RNasin (Promega, Madison, WI, USA), similar results.
Fig. 2. Immunohistologic staining of glomerular monocyte/macrophage
(M/M) infiltration. Immunohistologic staining of glomerular M/M infil-
tration with a ED-1 antibody revealed a marked increase of glomerular
ED-1 positive cells 24 hours after induction of the anti-rat-thymocyte
antiserum (ATS) nephritis (B) in comparison to the control group (A).
When the nephritic animal received AOP-RANTES, the glomerular
ED-1–positive cells were substantially reduced (24 hr; C; 3400).
Fig. 4. Immunohistologic staining of glomerular collagen type IV deposi-
tion. Immunohistologic staining of renal tissue with a collagen type IV
antibody demonstrated positivity in the glomerular mesangium and the
capillary walls in control animals (A). Kidney sections of nephritic
animals showed a increase of glomerular collagen type IV deposition
five days after induction of the nephritis (B). The treatment of nephritic
animals with AOP-RANTES leads to a significant reduction of glomeru-
lar collagen type IV deposition (C; 3400).
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Western blotting for RANTES and macrophage
inflammatory protein-1a
For Western blotting, glomeruli were isolated and cen-
trifuged in 1 3 phosphate-buffered saline (PBS). The
pellet was resuspended in 100 ml of Laemmli buffer (33%
vol/vol 0.5 mm Tris-HCl, pH 6.8, 66% vol/vol SDS 10%).
Samples were boiled for 10 minutes and centrifuged. The
protein concentration was determined with a modified
Lowry method (Protein DC-assay; Bio-Rad, Richmond,
CA, USA). Two equal amounts of protein (80 mg), 1⁄4
vol % of Laemmli buffer 2 (50% b-mercaptoethanol,
50% glycerol) were added. The solution was loaded onto
a polyacrylamide SDS-12% gel and was electrophoresed.
A low molecular weight marker (Rainbow marker; Am-
ersham, Braunschweig, Germany), which compromises
14.3 to 200 kDa, served as a molecular weight standard. Fig. 3. Glomerular collagen type IV deposition. The quantitative as-
sessment of glomerular collagen type IV deposition revealed that theAfter the completion of electrophoresis, proteins were
in vivo treatment with AOP-RANTES significantly reduced glomerularelectroblotted semidry (anode buffer I, 30 mm Tris, 20% collagen type IV deposition in nephritic animals at five days. *P 5 0.02.
methanol; anode buffer II, 300 mm Tris, 20% methanol;
cathode buffer, 25 mm Tris, 40 mm 6-amionohexane acid,
20% methanol) for 45 minutes at 0.8 mA/cm2 to a nitro-
described earlier [18]. For the evaluation of extracellularcellulose membrane (Hybond ECL; Amersham). The
collagen deposition, a modified score was used as de-membrane was blocked in 5% nonfat dry milk in washing
scribed earlier [18]. At least 80 glomeruli were evaluatedbuffer (1 3 PBS, 0.1% Tween 20) for one hour at room
in each kidney section from at least four animals pertemperature and was then incubated for another hour
time point. The percentage of glomerular matrix areawith a goat/anti-rat RANTES antibody or goat/anti-rat
stained by antitype IV collagen antibody was approxi-MCP-1 antibody (Santa Cruz Biotechnology, Inc., Santa
mated and classified applying a score consisting of gradesCruz, CA, USA) added to a concentration of 1:2000 in
0 through 4, grade 0 representing staining of 0 to 5% ofthe same buffer. As size standards, recombinant RANTES
the matrix area, grade 1 representing staining of 5 to(Pepro Tech, Inc., Rocky Hill, NJ, USA) and recombi-
20%, grade 2 staining 20 to 40%, grade 3 staining ofnant MCP-1 (Pepro Tech, Inc.) were used. After rinsing
40 to 60%, and grade 4 staining of more than 60%.the membrane in washing buffer for 3 3 10 minutes, the
Calculation of collagen deposition index was done in thesecondary antibody, a rabbit antigoat immunoglobin G
following way: The number of glomeruli with a score 1conjugated to horseradish peroxidase (Southern Biotech-
was multiplied by 1. Glomeruli with a score of 2 werenology, Birmingham, AL, USA) was added at a concen-
multiplied by 2. Those with a score of 3 were multipliedtration of 1:1000. The luminescence detection of peroxi-
by 3, and those with a score of 4 were multiplied by 4.dase was performed with ECL system according to the
These numbers were added and divided by the numbermanufacturer’s recommendations (Amersham) after rins-
of glomeruli assessed, including those with a score of 0.ing membranes in washing buffer 1 3 PBS films were
For the immunohistochemitry of MCP-1, the kidneysexposed 2 to 10 minutes at room temperature.
were snap frozen in liquid nitrogen, and 8 mm thick
Histology cryostat sections were prepared and then fixed in ace-
tone. The section were incubated with an anti-goat anti-Kidney tissues were either fixed in 1% buffered form-
rat MCP-1 antibody (Santa Cruz Biotechnology Inc.).aldehyde or in Methyl Carnoy’s solution. Tissue sections
After being incubated with biotin-conjugated second an-(2 mm) were stained with the APAAP complex following
tibody, the tissue sections were processed using a strep-an application of primary antibodies for immunohistol-
toavidin-biotin kit (ImmunoCruz Staining System; Santaogy. Tissue was stained with the following antibodies: A
Cruz Biotechnology). MCP-1 protein was visualized bygoat antitype IV collagen antibody (Biozol, Hamburg
incubation in peroxidase substrate, using diaminobenzi-Germany) and a monoclonal anti–ED-1 antibody (Chemi-
dine as chromogen.con International, Temecula, CA, USA). All quantita-
tive morphologic analyses were performed in a blinded
Statistical analysisfashion. Evaluation of ED-1–positive cells was performed
Results are expressed as means 6 sem unless statedby counting positive cells in at least 80 glomeruli (range
80 to 110) of at least four kidneys at each time point as otherwise. Statistical significance was defined as P , 0.05.
Fig. 5. Northern blot analysis. Glomerular mRNA levels of monocyte chemoattractant protein-1 (MCP-1) increased markedly at 24 hours and
slightly at 5 days when compared with controls. RANTES mRNA expression was not increased 24 hours after nephritis induction but increased
at 5 days. Animals treated with AOP-RANTES showed a similar RANTES and MCP-1 expression than nephritic animals.
Fig. 6. Reverse transcription-polymerase chain reaction (RT-PCR) of macrophage inflammatory protein-1a (MIP-1a). RT-PCR demonstrates that
MIP-1a RNA expression increases 24 hours after nephritis induction compared to control. Nephritic animals treated with AOP-RANTES showed
similar level of MIP-1a expression. Five days after nephritis induction, there were no differences in the MCP-1a expression compared with the control.
Panzer et al: AOP-RANTES reduces monocyte infiltration in GN2112
Table 1. Densitometric analysis of the RT-PCR and Northern blot experiments
ATS 1 AOP- ATS 1 AOP-
Control ATS RANTES Control ATS RANTES
24 hr 5 days
Northern blot experiments for RANTES (Fig. 5)
RANTES/18 S 0.76 0.89 0.93 0.87 1.41 1.14
% of control 100 117 122 100 162 131
Northern blot experiments for MCP-1 (Fig. 5)
MCP-1/18 S 0.24 2.1 1.7 0.47 1.12 1.14
% of control 100 875 725 100 238 242
RT-PCR experiments for MIP-1a (Fig. 6)
MIP-1a/GAPDH 0.043 0.136 0.196 0.167 0.223 0.219
% of control 100 316 455 100 133 131
Exposed films were quantitated by using phosphoimager. Experimental analyses were independently performed for three different complete sets of experiments
with qualitatively similar results.
To compare two distinct treatment groups (that is, ne- Glomerular collagen type IV deposition
phritic vs. control or nephritic vs. treated animals), we To study whether or not the AOP-RANTES treat-
applied the Mann–Whitney test. If not indicated other- ment affected extracellular matrix formation in glomeru-
wise, the results of the Mann–Whitney test always corre- lonephritis, the glomerular deposition of collagen type
sponded to a comparison of the nephritic versus treated IV as a marker of extracellular matrix formation was
animal. determined. In ATS nephritis, collagen type IV forma-
tion is markedly enhanced at day 5, as has been demon-
strated in earlier experiments [18]. The quantitative as-RESULTS
sessment revealed that AOP-RANTES reduced collagenWhite blood cell count
deposition (from 2.09 6 0.14 in nephritis to 1.45 6 0.7Application of ATS induced a significant fall in the
by almost 50% (P , 0.02; Figs. 3 and 4).white blood cell count from 10,900/ml to 5,030/ml cells
after three hours (P 5 0.02), which remained low up to
Chemokine mRNA expression24 hours. AOP-RANTES did not significantly influence
Glomerular mRNA expression of MCP-1 and MIP-1atotal white blood cells. Differential white blood cell
was hardly detectable in control animals, whereas therecount revealed that the reduction in total white blood
was a detectable basal expression of RANTES. Twenty-cells was due to the fall of lymphocytes. AOP-RANTES
four hours following the induction of glomerulonephritis,did not significantly change the differential cell count of
granulocytes and lymphocytes, but increased monocytes mRNA expression of MCP-1 and MIP-1a increased
at three hours (ATS 240/ml vs. ATS 1 AOP-RANTES markedly, whereas RANTES was unchanged. At five
960/ml, P 5 0.02) and not significantly increased them days, MCP-1 and MIP-1a mRNA levels fell, whereas
at 24 hours (ATS 790/ml vs. ATS 1 AOP-RANTES RANTES expression increased. The treatment of ne-
1280/ml, P 5 0.08, N 5 4 animals for each group). phritic rats with AOP-RANTES did not substantially
affect the expression of RANTES, MIP-1a, and MCP-1
Glomerular monocyte/macrophage infiltration
mRNA at 24 hours and 5 days (Figs. 5 and 6 and Table 1).
The induction of the glomerulonephritis resulted in a
significant increase of glomerular monocyte infiltration RANTES and macrophage inflammatory
from 0.33 6 0.14 cells/glomerula cross-section (c/gcs) in protein-1 expression
controls to 2.88 6 0.47 cells in nephritic rats at 24 hours
Western blot analysis revealed an increased glomerular(Figs. 1 and 2 A, B). Treatment of nephritic animals with
RANTES and MCP-1 protein expression after nephritisAOP-RANTES prevented glomerular monocyte recruit-
induction at 24 hours and 5 days. Treatment of nephriticment at 24 hours (nephritis 1 AOP-RANTES, 1.14 6
animals with AOP-RANTES does not substantially alter0.08 c/gcs, P , 0.02; Fig. 2C). Five days after the induc-
the expression of RANTES and MCP-1 at 24 hours andtion of the diseases, glomerular monocyte/macrophage
5 days (Fig. 7). Immunohistochemistry of MCP-1 showed(M/M) infiltration in nephritic rats was still significantly
a small amount of basal glomerular MCP-1 protein expres-higher than in controls (2.13 6 0.22 cells). AOP-RANTES–
sion and revealed an up-regulated protein expression intreated animals had less glomerular M/M (1.4 6 0.26)
nephritic animals (24 hr) and a similar level of expressionthan nephritic animals; however, the difference did not
reach statistical significance (P , 0.08). in nephritic animals treated with AOP-RANTES (Fig. 8).
Panzer et al: AOP-RANTES reduces monocyte infiltration in GN 2113
Fig. 7. Western blot analysis of RANTES and
monocyte chemoattractant protein-1 (MCP-1).
By Western blotting, glomerular RANTES
and MCP-1 were detectable as a band at the
size of 10 kDa, which was corresponding to
the size of recombinant RANTES and MCP-1
protein (data not shown). In nephritic rats, the
amounts of RANTES and MCP-1 were higher
compared with controls. Treatment of nephritic
animals with AOP-RANTES revealed a simi-
lar level of glomerular RANTES and MCP-1
protein expression at both time points.
Fig. 8. Immunohistologic staining of glomerular monocyte chemoattractant protein-1 (MCP-1) expression. Immunohistologic staining of glomerular
MCP-1 protein expression with an anti–MCP-1 antibody revealed a marked increased of glomerular MCP-1 24 hours after the induction of ATS
nephritis (B) in comparison to the control group (A). Treatment of nephritic animals with AOP-RANTES revealed a similar level of glomerular
MCP-1 protein. Staining with a negative control primary antibody (normal goat IgG) revealed no glomerular signal (D; 3400).
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DISCUSSION during the development of glomerulonephritis also im-
proves the disease progression. Animals treated withThe major finding of this study is that the chemokine
AOP-RANTES had a moderate reduction of extracellu-derivative, AOP-RANTES, a novel CCR-5 chemokine
lar matrix deposition. It remains unclear which factorsreceptor antagonist, prevents the glomerular infiltra-
mediated this effect; however, we recently found thattion of mnocytes in experimental glomerulonephrits by
MCP-1 stimulates transforming growth factor-b expres-over 60%.
sion in this glomerulonephritis and that anti–MCP-1 anti-Amino-oxypentane RANTES is a modified chemo-
body reduces glomerular collagen formation [18]. It seemskine that binds on monocytes with a high affinity to the
possible that other chemokines have similar effects. LloydCCR-5 chemokine receptor [12, 13]. CCR-5 is the natural
et al showed that the RANTES antagonist Met-RANTESreceptor of MIP-1a, MIP-1b, MCP-2, and RANTES, which
reduced the glomerular infiltration of inflammatory cellsinduce chemotaxis in monocytes [13, 19]. Our data sug-
in an anti-glomerular basement membrane glomerulone-gest that AOP-RANTES prevented glomerular mono-
phritis model but do not alter the glomerular extracellu-cyte infiltration by blocking the CCR-5 receptor, thereby
lar matrix deposition [19]. These differences may be ex-inhibiting monocyte chemotaxis. Indirect evidence for
plained through the different animal models and thesuch a mechanism derives from the finding that AOP-
higher effectivity of AOP-RANTES to down-regulateRANTES increased monocytes in the blood by more
the cell surface CCR-5 [13]. In summary, these data showthan 100% three hours after the induction of the disease,
that the CCR-5 receptor antagonist AOP-RANTES pre-whereas the appearance in the injured tissue was re-
vents the glomerular infiltration of monocytes in experi-duced. This suggests that the blockade of CCR-5 pre-
mental glomerulonephritis. This approach may offer newvented monocytes from migrating into inflamed tissues.
possibilities to treat autoimmune injuries with chemo-The evaluation of glomerular mRNA chemokine ex-
kine receptor-blocking approaches.pression revealed that 24 hours after induction of the
nephritis, MIP-1a as a ligand of CCR-5 was up-regulated,
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